
- /
- Supported exchanges
- / US
- / ALC.NYSE
Alcon AG (ALC NYSE) stock market data APIs
Alcon AG Financial Data Overview
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Alcon AG data using free add-ons & libraries
Get Alcon AG Fundamental Data
Alcon AG Fundamental data includes:
- Net Revenue: 10 025 M
- EBITDA: 2 342 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-19
- EPS/Forecast: 0.71
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Alcon AG News

STAAR Surgical holders should vote against sale to Alcon, ISS says (update)
[Documents about mergers and acquisitions m&a with a pen.] designer491/iStock via Getty Images UPDATE 3:20PM: Adds further details from ISS recommendation.STAAR Surgical (NASDAQ:STAA [https://seeking...


Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote "AGAINST" Sale to Alcon
ISS Joins Glass Lewis, Egan-Jones, and Long-Term Shareholders in Opposing Proposed Transaction Concludes There Is No Compelling Reason for Shareholders to Support Proposed Sale of STAAR Broadwood Ca...

Vernal Keratoconjunctivitis Research Report 2025: Market Led by Novartis, Alcon, and Santen, Innovation, Biologic Therapies, and Expanding Generics Drive Competitive Differentiation
Company Logo The VKC market is expanding due to increasing allergic ocular diseases, awareness, and access to therapies. Opportunities lie in Asia Pacific and the Middle East, driven by urbanization ...

Broadwood Partners Comments on STAAR Surgical’s Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon
STAAR Belatedly Acknowledges Alternative Interest in Acquiring the Company Reveals Entire Board Was Not Aware of Additional Interest When Recommending for Alcon Transaction Broadwood Urges All Share...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.